Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

Addiction

Volumn 95, Issue 4, 2000, Pages 575-590

  Valerie Curran, H ^a   Morgan, Celia ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE;

ADULT; AMNESIA; ANXIETY; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPERSONALIZATION; DEPRESSION; DRUG ABUSE; FEMALE; HUMAN; HYSTERIA; MALE; MOOD; PERCEPTION DISORDER; PSYCHOLOGIC ASSESSMENT; THOUGHT DISORDER;

EID: 0034011796     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2000.9545759.x     Document Type: Article

References (49)

1. ALLEN, R. M. & YOUNG, I. J. (1978) Phencyclidine-induced psychosis, American Journal of Psychiatry, 9, 477-501.
2. ANIS, N. A., BERRY, S. C., BURTON, N. R. & LODGE, D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively decrease excitation of central neurons by N-methyl-d-aspartate, British Journal of Pharmacology, 83, 179-185.
3. ASHTON, H. & YOUNG, M. D. (1999) Drug induced psychiatric disorders, in: DAVIES, D. M., FERNER, R. E. & DE GLENVILLE, H. (Eds) Davies' Textbook of Adverse Drug Reactions, pp. 669-731 (UK, Chapman Hall Medical Publications).
4. BADDELEY, A., EMSLIE, H. & NIMMO-SMITH, I. (1992) The Speed and Capacity of Language Processing (Reading, UK, Thames Valley Test Company).
5. BATTIG, W. F. & MONTAGUE, W. E. (1969) Category norms of verbal items in 56 categories: a replication and extension of the Connecticut norms, Journal of Experimental Psychology Monographs, 80 (2).
6. BISHOP, K. I. & CURRAN, H. V. (1995) Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist, flumazenil, Psychopharmacology, 121, 267-278.
7. BOND, A. J. & LADER, M. H. (1974) The use of analogue scales in rating subjective feelings, British Journal of Medical Psychology, 47, 211-218.
8. BREMNER, J. D., KRYSTAL, J. D., PUTMAN, F. W., SOUTHWICK, S. M., MARMAR, C., CHARNEY, D. S. & MAZURE, C. M. (1998) Measurement of dissociative states with the Clinician Administered Dissociative States Scale (CADSS), Journal of Traumatic Stress, 11, 125-136.
9. CLARIDGE, G. & BROKS, P. (1984) Schizotypy and hemisphere function: I. Theoretical considerations and the measurement of schizotypy, Personality and Individual Differences, 5, 633-648.
10. CLARIDGE, G., MCCREERCY, C., MASON, O., BENTALL, R., BOYLE, G., SLADE, P. & POPPLEWELL, D. (1996) The factor structure of "schizotypal" traits: a large replication study, British Journal of Clinical Psychology, 35, 103-115.
11. COTMAN, C. W. & MONAGHAN, D. T. (1987) Chemistry and anatomy of excitatory arnino acid systems, in: MELTZER, H. (Ed.) Psychopharmacology: the third generation of progress, pp. 197-210 (New York, Raven Press).
12. CURRAN, H. V. (1991) Benzodiazepines, memory and mood: a review, Psychopharmacology, 105.
13. CURRAN, H. V. (2000) Is MDMA ("ecstasy") neurotoxic in humans? An overview of evidence and of methodological problems in research, Neuropsychobiology, in press.
14. CURRAN, H. V. & GORENSTEIN, C. (1993) Differential effects of lorazepam and oxazepam on priming, International Clinical Psychopharmacology, 8, 37-42.
15. CURRAN, H. V. & TRAVILL, R. A. (1997) Mood and cognitive effects of 3, 4-methylenedioxymethamphetamine (MDMA, Ecstasy): weekend high followed by midweek low, Addiction 92, 821-831.
16. DALGARNO, P. & SHEWAN, D. (1996) Illicit use of ketamine in Scotland, Journal of Psychoactive Drugs, 28, 191-199.
17. ECKBLAD, M. & CHAPMAN, L. J. (1983) Magical ideation as an indicator of schizotypy, Journal of Consulting and Clinical Psychology, 51, 215-225.
18. FINE, J. & FINESTONE, S. C. (1973) Sensory disturbances following ketamine anesthesia: recurrent hallucinations, Anaesthesia and Analgesia, 52, 428-430.
19. GHONEIM, M. M., HINRICHS, J. M., MEWAUDT, S. P. & PETERSEN, R. C. (1985) Ketamine: behavioural effects of subanaesthetic doses, Journal of Clinical Psychopharmacology, 5, 71-77.
20. GRANT, I. S., NIMMO, W. S. & CLEMENTS, J. A. (1981) Pharmacokinetics analgesic effects of i.m. and oral ketamine, British Journal of Anaesthesiology, 53, 805.
21. HANSEN, G., JENSEN, S. B., CHANDRESH, L. & HILDEN, T. (1988) The psychotropic effect of ketamine, Journal of Psychoactive Drugs, 20, 419-425.
22. HARBOURNE, G. C., WATSON, F. L., HEALY, D. T. & GROVES, L. (1996) The effects of sub-anaesthetic does of ketamine on memory, cognitive performance and subjective experience in healthy volunteers, Journal of Psychopharmacology, 10, 134-140.
23. HARRIS, E. W., GANONG, A. H. & COTMAN, C. W. (1984) Long term potentiation in the hippocampus involves activation of N-methyl-d-aspartate receptors, Brain Research, 323, 132-137.
24. JANSEN, K. L. R. (1990) Ketamine - can chronic use impair memory? International Journal of the Addictions, 25, 133-139.
25. JAVITT, D. C. & ZUKIN, S. R. (1991) Recent advances in the phencyclidine model of schizophrenia, American Journal of Psychiatry, 148, 1301-1308.
26. JOHNSON, B.D. (1971) Psychosis and ketamine, British Medical Journal, iv, 428.
27. KOOB, G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends in Pharmacological Sciences, 13, 77-185.
28. KOVELMAN, J. & SCHEIBEL, A. (1984) A neurohistological correlate of schizophrenia, Biological Psychiatry, 19, 1601-1621.
29. KRYSTAL, J. H., KARPER, L. P., SEIBYL, J. P., FREEMAN, G. K., DELANEY, R., BREMNER, J. D., HENINGER, G. R., BOWERS, M. B. & CHARNEY, D. S. (1994) Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans, Archives of General Psychiatry, 51, 199-214.
30. KRYSTAL, J. H., KARPER, L. P., BENNETT, A., D'SOUZA, D. C., ABI-DARGHAM, A., MORRISSEY, K., ABI-SAAB, D., BREMNER, J. D., BOWERS, M. B., SUCKOW, R. F., STESON, P., HENINGER, G. R. & CHARNEY, D. S. (1998) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans, Psychopharmacology, 135, 213-229.
31. LAHTI, A. C., HOLCOMB, H. H., MEDOFF, D. R. & TAMMINGA, C. A. (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia, Neuroreport, 6, 869-872.
32. LUBY, E. D., COHEN, B. D., ROSENBAUM, G., GOTTLIEB, J. S. & KELLY, R. (1959) Study of a new psychotogenic drug, Archives of Neurological Psychiatry, 81, 113-119.
33. MALHOTRA, A. K., PINALS, D. A., WEINGARTNER, H., SIROCCO, K., MISSAR, C. D., PICKAR, D. & BREIER, A. (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy subjects, Neuropsychopharmacology, 14, 301-308.
34. MCKENKA, P. J., MORTIMER, A. M. & HODGES, J. R. (1992) Semantic memory and schizophrenia, in: DAVID, A. S. & CUTTING, J. C. (Eds) The Neuropsychology of Schizophrenia, pp. 163-177 (Hillsdale, Lawrence Erlbaum Associates).
35. MULLER, D., JOLY, M. & LYNCH, G. (1988) Contributions of quisqualate and NMDA receptors to the induction and expression of long-term potentiation, Science, 242, 1694-1697.
36. OYE, I., PAULSEN, O. & MAURSET, A. (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors, Pharmacological Experimental Therapy, 260, 1209-1213.
37. PEREL, A. & DAVIDSON, J. T. (1976) Recurrent hallucinations following ketamine, Anaesthesia, 31, 1081-1083.
38. PETERS, E., DAY, S., MCKENNA, J. & ORBACH, G. (1999) Delusional ideation in religious and psychotic populations, British Journal of Clinical Psychology, 38, 83-96.
39. RELEASE (1997) Release Drugs and Dance Survey London, UK, Release Publications.
40. SIEGEL, R. K. (1978) Phenylcyclidine and ketamine intoxication: a study of four populations of recreational users, in: PETERSON, R. C. & STILLMAN, R. C. (Eds) Phencyclidine Abuse: an appraisal, NIDA research monograph 21 (Rockville, Maryland, National Institute on Drug Abuse).
41. SIEGEL, R. K. & JARVIK, M. E. (1975) Drug induced hallucinations in animals and man, in: SIEGEL, R. K. & WEST, L. J. (Eds) Hallucinations, (New York, John Wiley & Sons).
42. SMITH, G. S., SCHLOESSER, R., BRODIE, J. D., DEWEY, S. L., LOGAN, J., VlTKUN, S. A., SIMKOVTTZ, P., HURLEY, A., COOPER, T., VOLKOW, N. D. & CANCRO, R. (1998) Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11-raclopride in normal human subjects, Neuropsychopharmacology, 18, 18-25.
43. SOLOWIJ, N., HALL, W. & LEE,N. (1992) Recreational MDMA use in Sydney: a profile of "Ecstasy" users and their experiences with the drug, British Journal of Addiction, 87, 1161-1172.
44. SOYKA, M., KRUPITSKI, G. & VOLKI, G. (1993) Phenomenology of ketamine induced psychosis, Sucht, 5, 327-331.
45. TAMLYN, D., MCKENNA, P. J., MORTIMER, A. M., LIND, C. E., HAMMOND, S. & BADDELEY, A. D. (1992) Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character, Psychological Medicine, 22, 101-115.
46. WILSON, B., COCKBURN, J. & BADDELEY, A. (1985) The Rivermead Behavioural Memory Test (Reading, UK, Thames Valley Test Co.).
47. WHEELER, M. A., STUSS, D. T. & TULVING, E. (1997) Toward a theory of episodic remembering: the frontal lobes and autonoetic consciousness, Psychological Bulletin, 121, 331-354.
48. WOZNIAK, D. F., MCEWEN, M., SESMA, M. A., OLNEY, J. W. & Fix, A. S. (1993) MK-801 induces neuronal necrosis in posterior/retrosplenial cortices, Neuroscience Abstracts, 19, 1770.
49. ZHANG, D. X. & LEVY, W. B. (1992) Ketamine blocks the induction of LTP at the lateral entorhinal cortex-dentate gyrus synapses, Brain Research, 593; 124-127.